It’s a record! Biotech IPO frenzy outpaces 2017 in half the time as 4 new arrivals on Nasdaq raise $556M
Between one Boston-based biotech run by some veteran stalwarts and two upstarts in the Bay Area, an extended hot streak of biotech IPOs has blasted …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
